Article

Health Characteristics Associated With Persistence of SARS-CoV-2 Antibody Responses After Repeated Vaccinations in Older Persons Over Time: The Doetinchem Cohort Study

2024-09-12

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Older persons elicit heterogeneous antibody responses to vaccinations that generally are lower than those in younger, healthier individuals. As older age and certain comorbidities can influence these responses we aimed to identify health-related variables associated with antibody responses after repeated SARS-CoV-2 vaccinations and its persistence thereafter in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a0cdbd54-0d64-5e03-b4a2-d2a27fe84b0e
DOI: 10.21203/rs.3.rs-4888786/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Health Characteristics Associated With Persistence of SARS-CoV-2 Antibody Responses After Repeated Vaccinations in Older Persons Over Time: The Doetinchem Cohort StudyDOI 10.21203/rs.3.rs-4888786/v1Read

Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adultsSemantic proximity Read

Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological dataSemantic proximity Read

Competent immune responses to SARS-CoV-2 variants in older adults following mRNA vaccinationSemantic proximity Read

Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and AgeSemantic proximity Read

SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody DynamicsSemantic proximity Read

Persistence of neutralizing antibodies a year after SARS-CoV-2 infectionSemantic proximity Read

Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adultsSemantic proximity Read

Dynamic Antibody Response in SARS-CoV-2 Infected Patients and COVID-19 Vaccine Recipients, and Vaccine Effectiveness in Comorbid and Multimorbid PatientsSemantic proximity Read

Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Elderly People Over 85 Years of Age in GreeceSemantic proximity Read

Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderlySemantic proximity Read

Immune Compromising Conditions Impair SARS-CoV-2 Vaccine Humoral Immunogenicity Despite Multiple Booster DosesSemantic proximity Read

A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjectsSemantic proximity Read